Best Pharmaceuticals Online Video

Alzheimer’s impacts nearly 7 million people in the United States. It’s a disease that literally robs people of what makes them who they are. For so long, Alzheimer’s disease has been a condition defined by hopelessness. But, as the first treatment proven to actually help people be themselves for longer, LEQEMBI is redefining what it means to meaningfully live with Alzheimer’s.

To bring the promise of our treatment to life, we needed to lean into the lived experiences of patients—real people and real situations. So, we developed a documentary style that invited viewers in and challenged their notions of what life with Alzheimer’s disease could be like.

Through the story of Paulette and her family, we’re finally showing a more hopeful reality.

Contributors:

Chief Creative Officer:	Dina Peck
VP, Group Account Supervisor:	Deborah Pultman
Group Project Management Supervisor:	Mushfeqa Hoque
Associate Partner, Group Creative Director:	Tom Galati
SVP, Creative Director, Art:	Nora Travis
VP, Associate Creative Director, Art:	Cara Gagne
SVP, Creative Director, Copy:	Ilyssa Berger Wilson
VP, Associate Creative Director, Copy :	Alex Siegal
Senior Medical Copy Editor:	Jennifer Anandarajah
VP, Supervising Producer:	Hilary Becker (Omnicom Studios)

PATIENTS & PURPOSE

Location: United States